[Implication of piribedil (pronoran) in the treatment of Parkinson's disease; a clinical and pharmacoeconomic analysis].
Mil'chakova
A E
AE
Popov
G R
GR
Bykov
A V
AV
Gekht
A B
AB
D000978:Antiparkinson Agents / Q000191:economics* / Q000627:therapeutic use*; D003365:Costs and Cost Analysis; D017850:Economics, Pharmaceutical / Q000706:statistics & numerical data*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy* / Q000191:economics; D010891:Piribedil / Q000191:economics* / Q000627:therapeutic use*; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D010891:Piribedil